Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04007393 · ClinicalTrials.gov registry record · Phase 2
SMART Use of Medication for the Treatment of Adolescent Severe Obesity
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT04007393 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 150 participants.
The verdict
NCT04007393, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study will examine the timing and sequence of using adjunct obesity pharmacotherapy for adolescents with severe obesity who do not respond to lifestyle modification therapy alone.
Interventions
- DRUG Placebo
- BEHAVIORAL Lifestyle Modification Therapy (LSMT)
- DRUG Phentermine Pill
- DRUG Topiramate Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-11-21 |
| Est. Completion | 2025-03-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04007393
The ClinicalTrials.gov registry entry for NCT04007393 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04007393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04007393 about?
NCT04007393 is a clinical study titled "SMART Use of Medication for the Treatment of Adolescent Severe Obesity". This study will examine the timing and sequence of using adjunct obesity pharmacotherapy for adolescents with severe obesity who do not respond to lifestyle modification therapy alone.
What is the current status of trial NCT04007393?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2019-11-21. Estimated completion is 2025-03-11.
What interventions are being tested in trial NCT04007393?
The interventions under investigation include: Placebo (DRUG), Lifestyle Modification Therapy (LSMT) (BEHAVIORAL), Phentermine Pill (DRUG), Topiramate Pill (DRUG).
Who is sponsoring clinical trial NCT04007393?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.